載入...
A heparin–rosuvastatin-loaded P(LLA-CL) nanofiber-covered stent inhibits inflammatory smooth-muscle cell viability to reduce in-stent stenosis and thrombosis
BACKGROUND: An endovascular covered-stent has unique advantages in treating complex intracranial aneurysms; however, in-stent stenosis and late thrombosis have become the main factors affecting the efficacy of covered-stent treatment. Smooth-muscle-cell phenotypic modulation plays an important role...
Na minha lista:
| 發表在: | J Nanobiotechnology |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8086342/ https://ncbi.nlm.nih.gov/pubmed/33926468 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12951-021-00867-8 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|